Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis

Lancet

Volumn 358, Issue 9281, 2001, Pages 522-523

  Geddes, Duncan M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANXIETY; BURKHOLDERIA CEPACIA; COST; CROSS INFECTION; CYSTIC FIBROSIS; ENVIRONMENT; EPIDEMIC; FAMILY; HUMAN; LUNG INFECTION; MORBIDITY; MORTALITY; NOTE; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK MANAGEMENT; SPUTUM CULTURE;

EID: 0035908783     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05742-7     Document Type: Note

References (8)

1. Hospital aquired infections
2. Burkholderia cepacia: Current clinical issues environmental controversies and ethical dilemmas
3. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonisation with Pseudomonas aeruginosa
4. Effects of Pseudomonas aeruginosa colonisation on lung function and anthropomorphic variables in children with cystic fibrosis
5. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years
6. Identifying treatments that halt progression of pulmonary disease in cystic fibrosis
7. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
8. Pseudomonas aeruginosa cross infection among patients with cystic fibrosis during a winter camp